Ультразвуковые эластография/эластометрия и стеатометрия при трансплантации печени

Актуальность. В настоящее время трансплантация печени остается наиболее эффективным методом лечения в основном терминальных стадий хронических диффузных заболеваний печени. Успех трансплантации зависит, в том числе, от адекватности выбора донорской печени, своевременной диагностики диффузных изменений трансплантата печени. В последние годы опубликованы многочисленные сообщения о применении при обследовании пациентов с хроническими диффузными заболеваниями печени ультразвуковых эластометрии/ эластографии и стеатометрии, значительно меньше публикаций о применении этих методов при трансплантации печени.

Цель. Обобщить современные данные об использовании ультразвуковых эластометрии/эластографии и стеатометрии на различных этапах трансплантации печени.

Материал и методы. Проведен анализ данных зарубежных и отечественных исследований, посвященных использованию различных методов ультразвуковых эластометрии/эластографии и стеатометрии в до- и послеоперационных периодах при трансплантации печени. Поиск литературных данных был произведен в международных базах данных (PubMed/MedLine/ResearchGate) и в научной электронной библиотеке России (eLIBRARY.RU) за период 2006–2024 годов.

Заключение. В проанализированных публикациях показана высокая информативность ультразвуковых эластометрии/эластографии и стеатометрии в выявлении фиброза и стеатоза донорской и трансплантированной печени, а также при отторжении трансплантата печени в послеоперационном периоде.

1. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: liver transplantation. J Hepatol. 2016;64(2):433–485. PMID: 26597456 https://doi.org/10.1016/j.jhep.2015.10.006

2. Won NY, Woo NCh, Woo PH, Rae ChH, Jun PS, Jong PH, et al. 83% 10 year survival rate after liver transplantation in 200 cases at a small volume center in Korea. Transplantation. 2020;104(S3):S514.

3. Crespo G, Lens S, Gambato M, Carrión JA, Mariño Z, Londoño MC, et al. Liver stiffness 1 year after transplantation predicts clinical outcomes in patients with recurrent hepatitis C. Am J Transplant. 2014;14(2):375–383. PMID: 24410892 https://doi.org/10.1111/ajt.12594

4. Rabindranath M, Zaya R, Prayitno K, Orchanian-Cheff A, Patel K, Jaeckel E, et al. A comprehensive review of liver allograft fibrosis and steatosis: from cause to diagnosis. Transplantation Direct. 2023;9(11):e1547. PMID: 37854023 https://doi.org/10.1097/TXD.0000000000001547

5. Mueller S. (ed.) Liver elastography: clinical use and interpretation. Springer; 2020.

6. Barr RG, Berzigotti G. (eds.) Multiparametric ultrasound for assessment of diffuse liver disease: a practical approach. Elsevier; 2023.

7. Ferraioli G, Barr RG, Berzigotti A, Sporea I, Wong VW, Reiberger T, et al. WFUMB Guideline/Guidance on Liver Multiparametric Ultrasound: Part 1. Update to 2018 Guidelines on Liver Ultrasound Elastography. Ultrasound Med Biol. 2024;50(8):1071–1087. PMID: 38762390 https://doi.org/10.1016/j.ultrasmedbio.2024.03.013

8. Ferraioli G, Barr RG, Berzigotti A, Sporea I, Wong VW, Reiberger T, et al. WFUMB Guidelines/Guidance on Liver Multiparametric Ultrasound. Part 2: Guidance on Liver Fat Quantification. Ultrasound Med Biol. 2024;50(8):1088– 1098. PMID: 38658207 https://doi.org/10.1016/j.ultrasmedbio.2024.03.014

9. Rigamonti C, De Benedittis C, Donato MF. Elastography in liver-transplanted patients. In: Fraquelli M. (ed.) Elastography of the liver and beyond. Springer Nature; 2021. p.75–89.

10. Winters AC, Mittal R, Schiano TD. A review of the use of transient elastography in the assessment of fibrosis and steatosis in the post–liver transplant patient. Clin Transplant. 2019;33(10):e13700. PMID: 31441967 https://doi.org/10.1111/ctr.13700

11. Augustin S, Pons M, Maurice JB, Bureau C, Stefanescu H, Ney M, et al. Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease. Hepatology. 2017;66(6):1980– 1988. PMID: 28696510 https://doi.org/10.1002/hep.29363

12. de Franchis R, Baveno VI Faculty. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743–752. PMID: 26047908 https://doi.org/10.1016/j.jhep.2015.05.022

13. Ripoll C, Groszmann R, GarciaTsao G, Grace N, Burroughs A, Planas R, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133(2):481– 488. PMID: 17681169 https://doi.org/10.1053/j.gastro.2007.05.024

14. Barr RG, Wilson SR, Rubens D, Garcia-Tsao G, Ferraioli G. Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement. Radiology. 2020;296(2):263–274. PMID: 32515681 https://doi.org/10.1148/radiol.2020192437

15. de Franchis R, Bosch J, GarciaTsao G, Reiberger T, Ripoll C; Baveno VII Faculty. Baveno VII – Re newing consensus in portal hypertension. J Hepatol. 2022;76(4):959–974. PMID: 35120736 https://doi.org/10.1016/j.jhep.2021.12.022

16. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–1321. PMID: 15915461 https://doi.org/10.1002/hep.20701

17. Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, et al. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(6):1717–30. PMID: 30689971 https://doi.org/10.1053/j.gastro.2019.01.042

18. Northup PG, Abecassis MM, Englesbe MJ, Emond JC, Lee VD, Stukenborg GJ, et al. Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost. Liver Transpl. 2009;15(2):148–162. PMID: 19177435 https://doi.org/10.1002/lt.21671

19. Lai JC, Pichardo EM, Emond JC, Brown RS Jr. Resource utilization of living donor versus deceased donor liver transplantation is similar at an experienced transplant center. Am J Transplant. 2009;9(3):586–591. PMID: 19191773 https://doi.org/10.1111/j.16006143.2008.02511.x

20. Muzaale AD, Dagher NN, Montgomery RA, Taranto SE, McBride MA, Segev DL. Estimates of early death, acute liver failure, and long-term mortality among live liver donors. Gastroenterology. 2012;142(2):273–280. PMID: 22108193 https://doi.org/10.1053/j.gastro.2011.11.015

21. Cuomo O, Perrella A, Pisaniello D, Marino G, Di Costanzo G. Evidence of liver histological alterations in apparently healthy individuals evaluated for living donor liver transplantation. Transplant Proc. 2008;40(6):1823–1826. PMID: 18675061 https://doi.org/10.1016/j.transproceed.2008.06.008

22. Новрузбеков М.С., Гуляев В.А., Луцык К.Н., Ахметшин Р.Б., Олисов О.Д., Магомедов К.М. и др. Программа трансплантации печени в НИИ скорой помощи имени Н.В. Склифосовского – этапы, достижения, перспективы. Вестник медицинского института «РЕАВИЗ». Реабилитация, Врач и Здоровье. 2020;(3):162–173.

23. Mancia C, Loustaud-Ratti V, Carrier P, Naudet F, Bellissant E, Labrousse F, et al. Controlled attenuation parameter and liver stiffness measurements for steatosis assessment in the liver transplant of brain-dead donors. Transplantation. 2015;99(8):1619–1624. PMID: 25719261 https://doi.org/10.1097/TP.0000000000000652

24. Yen YH, Kuo FY, Lin CC, Chen CL, Chang KC, Tsai MC, et al. Predicting hepatic steatosis in living liver donors via controlled attenuation parameter. Transplant Proc. 2018;50(10):3533–3538. PMID: 30577232 https://doi.org/10.1016/j.transproceed.2018.06.039

25. Liu WY, Li XX, Fu XY, Wu XD, Wang X, Guo Y, et al. Combination of liver graft sonographic grading and point shear wave elastography to reduce early allograft dysfunction after liver transplantation. Eur Radiol. 2020;30(9):5191–5199. PMID: 32328762 https://doi.org/10.1007/s00330-020-06842-5

26. Crespo G, Castro-Narro G, GarcíaJuárez I, Benítez C, Ruiz P, Sastre L, et al. Usefulness of liver stiffness measurement during acute cellular rejection in liver transplantation. Liver Transpl. 2016;22(3):298–304. PMID: 26609794 https://doi.org/10.1002/lt.24376

27. Monti L, Salsano M, Candusso M, Avolio AW, Soglia G, Marino M, et al. Diagnosis of acute rejection of liver grafts in young children using acoustic radiation force impulse imaging. AJR Am J Roengenol. 2020;215(5):1229– 1237. PMID: 32877250 https://doi.org/10.2214/AJR.19.22057

28. Andrade GM, Malbouisson LMS, Vezozzo DP, Andraus W, Mesquita PS, Albuquerque LAC, et al. Can elastography predict early allograft dysfunction or loss after liver transplantation? A prospective study of diagnostic accuracy. Clinics (Sao Paulo). 2025 May 1:80:100634. eCollection 2025. PMID: 40315798 https://doi.org/10.1016/j.clinsp.2025.100634

29. Banff Working Group; Demetris AJ, Adeyi O, Bellamy CO, Clouston A, Charlotte F, Czaja A, et al. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology. 2006;44(2):489– 501. PMID: 16871565 https://doi.org/10.1002/hep.21280 hep.21280

30. Carrion JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of advanced fbrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl. 2006;12(12):1791–1798. PMID: 16823833 https://doi.org/10.1002/lt.20857

31. Harada N, Soejima Y, Taketomi A, Yoshizumi T, Ikegami T, Yamashita Y, et al. Assessment of graft fbrosis by transient elastography in patients with recurrent hepatitis C after living donor liver transplantation. Transplantation. 2008;85(1):69–74. PMID: 18192914 https://doi.org/10.1097/01.tp.0000297248.18483.16

32. Blasco A, Forns X, Carrión JA, García-Pagán JC, Gilabert R, Rimola A, et al. Hepatic venous pressure gradient identifes patients at risk of severe hepatitis C recurrence after liver transplantation. Hepatology. 2006;43(3):492–499. PMID: 16496308 https://doi.org/10.1002/hep.21090

33. Fraquelli M, Rigamonti C, Casazza G, Donato MF, Ronchi G, Conte D, et al. Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C. J Hepatol. 2011;54(4):621–628. PMID: 21146243 https://doi.org/10.1016/j.jhep.2010.07.017

34. Donato MF, Rigamonti C, Colombo M. Can protocol liver biopsy be avoided to evaluate posttransplant hepa titis C recurrence? Transient elastography makes it possible. Dig Liver Dis. 2010;42(4):307. PMID: 19709938 https://doi.org/10.1016/j.dld.2009.07.015

35. Carrión JA, Torres F, Crespo G, Miquel R, García-Valdecasas JC, Navasa M, et al. Liver stiffness identifes two different patterns of fbrosis progression in patients with hepatitis C virus recurrence after liver transplantation. Hepatology. 2010;51(1):23–34. PMID: 19839063 https://doi.org/10.1002/hep.23240

36. Rigamonti C, Donato MF, Colombo M. Transient elastography in the early prediction of progressive recurrent hepatitis C following liver transplantation. Hepatology. 2010;52(2):800–801. PMID: 20683975 https://doi.org/10.1002/hep.23607

37. Gambato M, Crespo G, Torres F, LLovet L, Carrión J, Londoño M, et al. Simple prediction of long-term clinical outcomes in patients with mild hepatitis C recurrence after liver transplantation. Transpl Int. 2016;29(6):698–706. PMID: 26661662 https://doi.org/10.1111/tri.12730

38. Yoon JH, Lee JY, Woo HS, Yu MH, Lee ES, Joo I, et al. Shear wave elastography in the evaluation of rejection or recurrent hepatitis after liver transplantation. Eur Radiol. 2013;23(6):17291737. PMID: 23300037 https://doi.org/10.1007/s00330-012-2748-z

39. Belli LS, Perricone G, Adam R, Cortesi PA, Strazzabosco M, Facchetti R, et al. Impact of DAAs on liver transplantation: major effects on the evolution of indications and results. An ELITA study based on the ELTR registry. J Hepatol. 2018;69(4):810–817. PMID: 29940268 https://doi.org/10.1016/j.jhep.2018.06.010

40. Mauro E, Crespo G, Montironi C, Londono MC, Hernandez-Gea V, Ruiz P, et al. Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after SVR in recurrent hepatitis C. Hepatology. 2018;67(5):1683–1694. PMID: 28960366 https://doi.org/10.1002/hep.29557

41. Rigamonti C, Fraquelli M, Bastiampillai AJ, Caccamo L, Reggiani P, Rossi G, et al. Transient elastography identifies liver recipients with nonviral graft disease after transplantation: a guide for liver biopsy. Liver Transpl. 2012;18(5):566–576. PMID: 22271627 https://doi.org/10.1002/lt.23391

42. Bhat M, Tazari M, Sebastiani G. Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: a meta-analysis. PloS one. 2017;12(9):e0185192. PMID: 28953939 https://doi.org/10.1371/journal.pone.0185192

43. Deurdulian C, Grant EG, Tchelepi H, Latterman PT, Paluch JT, Chopra S, et al. Assessment of fibrosis in liver transplant recipients: diagnostic performance of Shear Wave Elastography (SWE) and correlation of SWE findings with biopsy results. AJR. 2019;213(6):W264–W271. PMID: 31573849 https://doi.org/10.2214/AJR.19.21160

44. Lee DH, Lee JY, Bae JS, Yi NJ, Lee KW, Suh KS, et al. Shear-wave dispersion slope from US shear-wave elastography: detection of allograft damage after liver transplantation. Radiology. 2019;293(2):327–333. PMID: 31502939 https://doi.org/10.1148/radiol.2019190064

45. Bosselmann EA, Engel B, Hartleben B, Wedemeyer H, Jaeckel E, Maasoumy B, et al. Prospective comparison of liver stiffness measurement methods in surveillance biopsies after liver transplantation. Front Transplant. 2023;2:1148195. PMID: 38993851 https://doi.org/10.3389/frtra.2023.1148195

46. Рыхтик П.И., Рябова Е.Н., Муртазалиева М.С., Васенин С.А., Шкалова Л.В., Загайнов В.Е. Комплексное обследование пациентов после трансплантации печени с использованием ARFI-эластографии. Ультразвуковая и функциональная диагностика. 2015;(5S: тезисы VII Съезда Рос. Ассоциации специалистов ультразвуковой диагностики в медицине (Москва, 10–13 ноября 2015). Часть 2):148–149.

47. Vij M, Rammohan A, Rela M. Longterm liver allograft fibrosis: A review with emphasis on idiopathic post-transplant hepatitis and chronic antibody mediated rejection. World J Hepatol. 2022;14(8):1541–1549. PMID: 36157865 https://doi.org/10.4254/wjh.v14.i8.1541

48. Hübscher S. What does the long-term liver allograft look like for the pediatric recipient? Liver Transpl. 2009;15(Suppl 2):S19–S24. PMID: 19877293 https://doi.org/10.1002/lt.21902

49. Angelico R, Spada M, Liccardo D, Pedini D, Grimaldi C, Pietrobattista A, et al. Allograft fibrosis after pediatric liver transplantation: incidence, risk factors, and evolution. Liver Transpl. 2022;28(2):280–293. PMID: 34164907 https://doi.org/10.1002/lt.26218

50. Perito ER, Persyn E, Bucuvalas J, Martinez M, Mohammad S, Squires JE, et al. Graft fibrosis over 10 to 15 years in pediatric liver transplant recipients: multicenter study of paired, longitudinal surveillance biopsies. Liver Transpl. 2022;28(6):1051–1062. PMID: 35029022 https://doi.org/10.1002/lt.26409

51. Cetinic I, de Lange Ch, Boström H, Ekvall N, Bennet W, Lagerstrand K, et al. Shear wave elastography and shear wave dispersion correlated to biopsy at the scheduled follow-up of pediatric liver grafts. Pediatric Transplantation. 2023;27(7):e14591. PMID: 37583096 https://doi.org/10.1111/petr.14591

52. Contos MJ, Cales W, Sterling RK, Luketic VA, Shiffman ML, Mills AS, et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl. 2001;7(4):363–373. PMID: 11303298 https://doi.org/10.1053/jlts.2001.23011

53. Karlas T, Kollmeier J, Böhm S, Müller J, Kovacs P, Tröltzsch M, et al. Noninvasive characterization of graft steatosis after liver transplantation. Scand J Gastroenterol. 2015;50(2):224–232. PMID: 25429378 https://doi.org/10.3109/00365521.2014.983156

54. Chayanupatkul M, Dasani DB, Sogaard K, Schiano TD. The utility of assessing liver allograft fibrosis and steatosis post-liver transplantation using transient elastography with controlled attenuation parameter. Transplant Proc. 2021;53(1):159–165. PMID: 32434740 https://doi.org/10.1016/j.transproceed.2020.02.160

55. Рыхтик П.И., Рябова Е.Н., Демин И.Ю., Горшенина Е.С., Сафонов Д.В. Опыт применения дисперсии сдвиговых волн у пациентов после трансплантации печени. Радиология – практика. 2023;6(102):22–33. https://doi.org/10.52560/2713-0118-2023-6-22-33

56. Rinaldi L, Valente G, Piai G. Serial liver stiffness measurements and monitoring of liver transplanted patients in a real-life clinical practice. Hepat Mon. 2016;16(12):e41162. PMID: 28123442 https://doi.org/10.5812/hepatmon.41162

57. Chin JL, Chan G, Ryan JD, McCormick PA. Spleen stiffness can non-invasively assess resolution of portal hypertension after liver transplantation. Liver Int. 2015;35(2):518–523. PMID: 25074281 https://doi.org/10.1111/liv.12647

58. Friedrich K, Mehrabi A, Pfeiffenberger J, Rupp C, Weiss KH, Mieth M. Spleen transient elastography predicts actuarial survival after liver transplantation. Transl Gastroenterol Hepatol. 2022;(7):31. PMID: 35892053 https://doi.org/10.21037/tgh-19-343